Abstract
Millions of newborn infants all over the world are screened today for phenylketonuria (PKU), and many thousands of early-treated children and young persons are bright and completely normal. Research workers from many disciplines have cooperated to elucidate the biochemical and genetic background of PKU and other hyperphenylalaninemias and to prevent these inherited metabolic errors before clinical symptoms appear. This is a brief summary of the history of hyperphenyl-alaninemia covering a period of five decades from the time of Følling’s first publication in 1934.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Armstrong, M.D., and Robinson, K.S. (1984). On the excretion of indole derivatives in phenylketonuria. Arch. Biochem. 52:287–288.
Bartholomé, K., Lutz, P., and Bickel, H. (1975). Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylala-ninemia. Pediatr. Res. 9:899–903.
Bickel, H., Gerrard, J., and Hickmans, E.M. (1954). The influence of phenylalanine intake on the chemistry and behavior of a phenylketonuria child. Acta Paediatr. Scand. 43:64–77.
Bickel, H., Hudson, F.P., and Woolf, L.I. (1971). Phenylketonuria and some other inborn errors of metabolism. Stuttgart: Georg Thiese Verlag.
Bickel, H., Beckers, R.G., Wamberg, E., Schmid-Rüter, E., Feingold, J., Cahalane, S.F., Bottine, E., Jonxis, J.H.P., Colombo, J.P., and Carson, N. (1973). Collective results of mass screening for inborn metabolic errors in eight European countries. Acta Paediatr. Scand. 62:413–16.
Brunner, R.L., Jordan, M.K., and Berry, H.K. (1983). Early treated phenylketonuria: neuropsychologic consequences. J. Pediatr. 102:831–835.
Butler, L.J., O’Flynn, M.E., Seifert, W.E., and Howell, R.R. (1981). Neurotransmitter defects and treatment of disorders of hyperphenylalaninemias. J. Pediatr. 78:729–733.
Cabalska, B., Duszynska, N., Borzymowska, J, Zorska, K., Koslacz-Folga, A., and Bozkowa, K. (1977). Termination of dietary treatment in phenylketonuria. Eur. J. Pediatr. 126:126–253.
Curtius, H.-Ch., Vollmin, J.A., and Baerlocher, K. (1972). The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism. Clin. Chim. Acta 37:277–285.
Curtius H.-Ch., Niederwieser, A., Viscontini, M., Otten, A., Schaub, J., Scheibenreiter, S., Schmidt, H. (1979). Atypical phenylketonuria due to tetra-hydrobiopterin deficiency, diagnoses and treatment with tetrahydrobiopterin, dihydrobiopterin and sepiapterin. Clin. Chem. Acta. 93:251–262.
Curtius, H.-Ch., Niederwieser, A., Viscontini, M., Leimbacher, W., Wegman, H., Blehova, B., Rey, F., Schaut, J., and Schmidt, H. (1981). Serotonin and dopamine synthesis in phenylketonuria. Adv. Exp. Med. Biol. 133:277–291.
Daiger, S., Lidsky, A.S., Chakraborty, R., Koch R., Güttier, F., and Woo, S.L.C. (1986). Effective use of polymorphic DNA haplotypes at the phenylalanine hydroxylase locus in prenatal diagnosis of phenylketonuria. Lancet i:229–232.
DiLella, A.G., Kwok, S.C.M., Ledley, F.D., Marvit, J., and Woo, S.L.C. (1986a). Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene. Biochemistry 25:743–749.
DiLella, A.G., Marvit, J., Lidsky, A.S., Güttier, F., and Woo, S.L.C. (1986b). Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria. Nature 322:799–803.
Følling, A. (1934). Uber Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität. Z. Physiol. Chem. 227:169–176.
Guthrie, R., and Susi, A. (1963). A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32:338–43.
Güttier, F. (1971). Persistent hyperphenylalaninemia. Scand. J. Clin. Lab. Invest, Suppl. 118:48.
Güttier, F. (1980). Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood. Acta Pædiatr. Scand. Suppl. 280:1–80.
Güttier, F. (1984). Phenylketonuria: 50-Years since Følling’s discovery and still expanding our clinical and biochemical knowledge. Acta Paediatr. Scand. 73:705–716.
Güttier, F., and Lou, H. (1986). Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function. J. Inher. Metab. Dis. 9(Suppl. 2):169–177.
Güttier, F., and Wamberg, E. (1972). Persistent hyperphenylalaninemia. Acta Paediatr. Scand. 62:333–337.
Güttier, F., and Woo, S.L.C. (1985). Molecular genetics of PKU: prenatal diagnosis and carrier detection by gene analysis. In Bicke, H., and Wachtel, H. (eds.), Recent progress in the understanding, recognition and management of inherited diseases of amino acid metabolism. Stuttgart: Georg Thieme Verlag, pp. 18–36.
Güttier, F., and Woo, S.L.C. (1986). Molecular genetics of PKU. J. Inher. Metab. Dis. 9(Suppl. l):58–68.
Güttier, F., Lou, H., Lykkelund, C., and Niederwieser, A. (1984). Combined tetrahydrobiopterin-phenylalanine loading test in the detection of partially defective biopterin synthesis. Eur. J. Pediatr. 141:136–139.
Güttier, F., Ledley, F.D., Lidsky, A.S., DiLella, A.G., Sullivan, S.E., and Woo, S.L.C. (1987). Correlation between polymorphic DNA haplotypes at the phenylalanine hydroxylase locus and clinical phenotypes at the phenylketonuria. J. Pediatr. 110:68–71.
Hsia, D.Y.Y., Driscoll, K.W., Troll, W., and Knox, W.E. (1956). Detection by phenylalanine tolerance tests of heterozygous carriers of phenylketonuria. Nature 178:1239–40.
Jervis, G.A. (1953). Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system. Proc. Soc. Exp. Biol. Med. 82:514–515.
Kaufman, S. (1957). The enzymatic conversion of phenylalanine to tyrosine. J. Biol. Chem. 226:511–524.
Kaufman, S. (1959). Studies on the mechanism of the enzymatic conversion of phenylalanine to tyrosine. J. Biol. Chem. 234:2677–2682.
Kaufman, S. (1976). Phenylketonuria: biochemical mechanisms. In Agranoff, B.W., and Aprison, M.H. (eds.), Advances in neurochemistry, Vol 2. New York: Plenum Press, pp. 1–132.
Kaufman, S., Holtzman, N.A., Milstien, S., Butler, I.J., and Krumholtz, A. (1975). Phenylketonuria due to a deficiency of dihydropteridine reductase. N. Engl. J. Med. 293:673–79.
Kaufman, S., Berlow, S., Summer, G.K., Milstien, S., Schulman, J.D., Orloff, S., Spielberg, S., and Pueschel, S. (1978). Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria. N. Engl. J. Med. 299:673–79.
Kaufman, S., Kapatos, G., McInnes R.R., Schulman, J.D., and Rizzo, W.B. (1982). Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain. Pediatrics 70:376–380.
Koch, R., Azen, C.G., Friedman, E.G., and Williamson, M.L. (1982). Preliminary report on the effects of diet discontinuation in PKU. Pediatrics 100:870–75.
Krause, W., Halminski, M., McDonald, L., Dembure, P., Salvo, R., Freides, D., and Elsas, L. (1985). Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. J. Clin. Invest. 75:40–48.
Krause, W., Epstein, C., Averbook, A., Dembure, P., and Elsas, L. (1986). Phenylalanine alters the mean power frequency of electroencephalograms and plasma L-DOPA in treated patients with phenylketonuria. Pediatr. Res. 20:1112–1116.
Kwok, S.C.M., Ledley, F.D., DiLella, A.G., Robson, K.J.H., and Woo, S.L.C. (1985). Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase. Biochemistry 24:556–61.
Ledley, F.D., Grenett, H.E., DiLella, A.G., Kwok, S.C.M., and Woo, S.L.C. (1985): Gene transfer and expression of human phenylalanine hydroxylase. Science 228:77–79.
Ledley, F.D., Levy, H.L., and Woo, S.L.C. (1986). Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders. N. Engl. J. Med. 314:1276–1280.
Leeming, R.J., Blair, J.A., and Rey, F. (1976). Biopterin derivates in atypical phenylketonuria. Lancet i:99.
Lenke, R.R., and Levy, H.L. (1980). Maternal phenylketonuria and hyperphenyl-alaninemias. An international survey of the outcome of untreated and treated pregnancies. N. Engl. J. Med. 309:1269–1274.
Levy, H.L., and Waisbren, S.E. (1983). Effects of untreated phenylketonuria and hyperphenylalaninemia on the fetus. N. Engl. J. Med. 309:1269–1274.
Levy, H.L., Shih, V.E., Karolkewicz, V., French, W.A., Carr, J.R., Cass, V., Kennedy, J.L., and MacCready, R.A. (1971). Persistent mild hyperphenylalaninemia in the untreated state. A prospective study. N. Engl. J. Med. 285:424–429.
Lidsky, A.S., Güttier, F., and Woo, S.L.C. (1985a). Prenatal diagnosis of classic phenylketonuria by DNA analysis. Lancet i:549–551.
Lidsky, A.S., Ledley, F.D., DiLella, A.G., Kwok, S.C.M., Daiger, S.P., Robson, K.J.H., and Woo, S.L.C. (1985b). Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am. J. Hum. Genet. 37:619–634.
Lidsky, A.S., Law, M.L., Morse, H.G., Kao, F.T., and Woo, S.L.C. (1985c). Regional mapping of the human phenylalanine hydroxylase gene and the PKU locus on chromosome 12. Proc. Natl. Acad. Sci. USA 82:6221–6225.
Lou, H.C., Güttier, F., Lykkelund, C., Bruhn, P., and Niederwieser, A. (1985). Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur. J. Pediatr. 144:17–20.
Lou, H.C., Lykkelund, C., Gerdes, A.-M., Udesen, H., and Bruhn, P. (1987). Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Pædiatr. Scand. 76:560–565.
Lykkelund, C., Lou, H.C., Rasmussen, V., and Güttier, F. (1985). Biopterin, neopterin and tyrosine responses to combined oral phenylalanine and tetrahydro-biopterin loading tests in two normal children and in a girl with partial biopterin deficiency. J. Inher. Metab. Dis. 8(Supp. 2):95–96.
McKean, C.M. (1972). The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain. Brain Res. 47:469–476.
Mitoma, C. (1956). Studies on partially purified phenylalanine hydroxylase. Arch. Biochem. Biophys. 60:476–484.
Nadler, H.L., and Hsia, D.Y.Y. (1961). Epinephrine metabolism in phenylketonuria. Proc. Soc. Exp. Biol. Med. 107:721–722.
Niederwieser, A., Curtius, H.-Ch., Wang, M., and Leupold, D. (1982). Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetra-hydrobiopterin or sepiapterin: screening and study of biosynthesis in man. Eur. J. Pediatr. 138:110–112.
Niederwieser, A., Blau, N., Wang, M., Joller, P., Atarés, M., and Cardesa-Garcia, J. (1984). GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur. J. Pediatr. 141:208–214.
Pare, C.M., Sandler, M., and Stacey, R.S. (1957): 5-Hydroxytryptamine deficiency in phenylketonuria. Lancet 551–553.
Perry, T.L., Hansen, S., Tischler, B., Richards, F.M., and Sokol, M. (1973). Unrecognized adult phenylketonuria. Implications for obstetrics and psychiatry. N. Engl. J. Med. 289:395–398.
Robson, K.J.H., Chandra, T., MacGillivray, R.T.A., and Woo, S.L.C. (1982). Polysome immunoprecipitation of phenylalanine hydroxylase mRNA from rat liver and cloning of its cDNA. Proc. Natl. Acad. Sci. USA, 79:4701–4705.
Smith, I., Lobascher, M.E., Stevenson, J.E., Wolff, O.H., Schmidt, H. Grubel-Kaiser, S., and Bickel, H. (1978). Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria. Br. Med. J. II:723–726.
Udenfriend, S., and Cooper, J.R. (1952). The enzymatic conversion of phenylalanine to tyrosine. J. Biol. Chem. 194:503–511.
Waisbren, S.E., Schnell, R.R., and Levy, H.L. (1980). Diet termination in children with PKU. A review of psychological assessments used to determine outcome. J. Inher. Metab. Dis. 3:149–153.
Weil-Malherbe, H. (1955). Blood adrenaline and intelligence. J. Ment. Sci. 101:733–745.
Woo, S.L.C., Gilliam, S.S., and Woolf, L.I. (1974). The isolation and properties of phenylalanine hydroxylase from human liver. Biochem. J. 139:741–749.
Woo, S.L.C., Lidsky, A.S., Güttier, F., Chandra, T., and Robson, K.J.H. (1983). Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria. Nature 306:151–155.
Woo, S.L.C., Lidsky, A.S., Güttier, F., Chandra, T., and Robson, K.J.H. (1984). Prenatal diagnosis of classical phenylketonuria by gene mapping. J. Am. Med. Assoc. 251:1998–2002.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Birkhäuser Boston
About this chapter
Cite this chapter
Güttler, F. (1988). Epidemiology and Natural History of Phenylketonuria and Other Hyperphenylalaninemias. In: Wurtman, R.J., Ritter-Walker, E. (eds) Dietary Phenylalanine and Brain Function. Birkhäuser Boston. https://doi.org/10.1007/978-1-4615-9821-3_26
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9821-3_26
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4615-9823-7
Online ISBN: 978-1-4615-9821-3
eBook Packages: Springer Book Archive